For example, a recent study demonstrated that patients with non-small cell lung cancer showed an increased risk for radiation pneumonitis with increased TGF-β signaling (48), while a preclinical study demonstrated a decrease risk for radiation pneumonitis in mice treated with TGF-β inhibition (49). The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.